A new therapy for type 1 diabetes could nix the need for insulin injections. Just a single infusion of lab-grown pancreatic cells let patients’ bodies make all the insulin they needed, scientists ...
These factors could provide a scientific basis for consistency evaluations of the quality and efficacy of insulin biosimilars, study authors wrote. Factors that may affect the bioequivalence of test ...
section 1. Basic principles -- section 2. Dietary treatment of diabetes -- section 3. Treatment with insulin preparations -- section 4. Complications of diabetes -- section 5. Preparations of iletin ...
Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...
The European Medicines Agency (EMA) has updated its guideline on the requirements for clinical and non-clinical development of biosimilar insulin products. The update expands the scope of the original ...
Hosted on MSN
What Is Regular Insulin?
Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results